U.S. NON-ONCOLOGY BIOPHARMACEUTICALS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2026 - 2033)

  • Biologics
  • Biosimilars

• Drug Class Insights (Revenue, USD Bn, 2026 - 2033)

  • Monoclonal Antibody
  • Enzyme Replacement Therapy
  • Erythropoietin
  • Interferon
  • Colony-stimulating Factor
  • Botulinum Toxin
  • Fusion Protein
  • Vaccines
  • Human Recombinant Insulin
  • Blood Factors
  • Human Growth Hormone
  • Others

• Disease Indication Insights (Revenue, USD Bn, 2026 - 2033)

  • Diabetes
  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Multiple Sclerosis
  • Hemophilia
  • Anemia
  • Age-related Macular Degeneration
  • Hepatitis B
  • Cystic Fibrosis
  • Osteoporosis
  • Crohn’s Disease
  • Ulcerative Colitis
  • Psoriasis
  • Ankylosing Spondylitis
  • Others (Cardiac diseases and others)